Diagnostic Gleason score and castration-resistant prostate cancer

Ann Oncol. 2016 Jun;27(6):962-964. doi: 10.1093/annonc/mdw179. Epub 2016 Apr 18.

Authors

A Jayaram¹, G Attard²

Affiliations

¹ Centre for Evolution and Cancer, Division of Molecular Pathology, The Institute of Cancer Research, London; The Royal Marsden NHS Foundation Trust, London, UK.
² Centre for Evolution and Cancer, Division of Molecular Pathology, The Institute of Cancer Research, London; The Royal Marsden NHS Foundation Trust, London, UK. Electronic address: [email protected].

PMID: 27091809
DOI: 10.1093/annonc/mdw179

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Humans
Male
Neoplasm Grading*
Prostate-Specific Antigen
Prostatic Neoplasms
Prostatic Neoplasms, Castration-Resistant*

Substances

Prostate-Specific Antigen

Grants and funding